Prospective Studies Team Partnered with Lundbeck on Accepted Manuscript in Movement Disorders: Clinical Practice
January 22, 2019
Xcenda's expertise in prospective studies highlighted in high-profile publication, Movement Disorders Clinical Practice. This study was developed in partnership with Lundbeck and examined the real‐world experience of patients taking droxidopa after 6 months of treatment.
ACCEPTED PROSPECTIVE STUDIES MANUSCRIPT
6‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension
Xcenda was proud to partner with Lundbeck on the development of the accepted manuscript titled, 6‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension, for publication.
Xcenda authors: Amy M. Duhig, PhD; Kim McLeod, MPH; Augustina Ogbonnaya, MPH; Apryl Quillen, MS; Binglin Yue, MS
ADD DEPTH TO PRODUCT VALUE PROPOSITION POST-LAUNCH
Prospective Studies
Turn to our team of experts to design and conduct in-depth studies to collect a variety of endpoints. Leverage our full-service support, including protocol development, site selection, and management. IRB submissions and approvals, development and maintenance of EDC tools, patient recruitment statistical analysis, and preparation of final study reports.
